Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,773.00
-24.00 (-1.34%)
Apr 29, 2026, 3:30 PM KST

Xcell Therapeutics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Cash & Equivalents
2,0947,7641,2395,43614,632
Upgrade
Short-Term Investments
30035.67120120-
Upgrade
Trading Asset Securities
4,5121,002---
Upgrade
Cash & Short-Term Investments
6,9068,8021,3595,55614,632
Upgrade
Cash Growth
-21.54%547.78%-75.55%-62.03%119.39%
Upgrade
Accounts Receivable
-114.0954.71282.87264.4159.42
Upgrade
Other Receivables
476.74455.24333.93368.52109.59
Upgrade
Receivables
362.65509.96616.8632.92269.01
Upgrade
Inventory
1,327697.92804.25686.9500.67
Upgrade
Prepaid Expenses
322.3110.6---
Upgrade
Other Current Assets
718.66491.1960.41339.8922.45
Upgrade
Total Current Assets
9,63710,5122,8407,21615,425
Upgrade
Property, Plant & Equipment
4,1934,4725,3557,3727,515
Upgrade
Long-Term Investments
879.61,09934.7831.6919.81
Upgrade
Other Intangible Assets
694.06537.35125.05307.51238.75
Upgrade
Long-Term Accounts Receivable
-0-0-0-0-0
Upgrade
Other Long-Term Assets
317.7269.812,113582.39503.45
Upgrade
Total Assets
15,72116,89010,46815,50923,702
Upgrade
Accounts Payable
217.14125.57133.6690227.29
Upgrade
Accrued Expenses
344.28295.36263.38277.52244.79
Upgrade
Short-Term Debt
3,5003,5004,0004,0004,000
Upgrade
Current Portion of Long-Term Debt
116.6487.5672.5--
Upgrade
Current Portion of Leases
447.59465.62589.68449.1453.31
Upgrade
Other Current Liabilities
706.2432.39383.32370.56332.31
Upgrade
Total Current Liabilities
5,3324,9065,4435,1875,258
Upgrade
Long-Term Debt
1,0161,1321,148870870
Upgrade
Long-Term Leases
406.73515.99695.9527.77868.12
Upgrade
Pension & Post-Retirement Benefits
1,130693.4288.17-93.87
Upgrade
Other Long-Term Liabilities
699.43520.26510.64440.67387.31
Upgrade
Total Liabilities
8,5837,7698,0857,0267,477
Upgrade
Common Stock
8,6475,4594,5824,3804,376
Upgrade
Additional Paid-In Capital
64,14057,99342,71139,91339,860
Upgrade
Retained Earnings
-66,666-55,717-46,071-36,835-28,407
Upgrade
Comprehensive Income & Other
1,0171,3861,1621,025395.85
Upgrade
Total Common Equity
7,1389,1212,3848,48316,225
Upgrade
Shareholders' Equity
7,1389,1212,3848,48316,225
Upgrade
Total Liabilities & Equity
15,72116,89010,46815,50923,702
Upgrade
Total Debt
5,4875,7026,5065,8476,191
Upgrade
Net Cash (Debt)
1,4193,100-5,147-290.758,441
Upgrade
Net Cash Growth
-54.22%---378.96%
Upgrade
Net Cash Per Share
121.84309.93-581.98-33.211019.25
Upgrade
Filing Date Shares Outstanding
17.2910.929.168.768.75
Upgrade
Total Common Shares Outstanding
17.2910.929.168.768.75
Upgrade
Working Capital
4,3055,605-2,6022,02910,167
Upgrade
Book Value Per Share
412.74835.38260.10968.501854.01
Upgrade
Tangible Book Value
6,4448,5842,2588,17615,986
Upgrade
Tangible Book Value Per Share
372.61786.16246.46933.391826.73
Upgrade
Land
370.53370.53370.531,9711,971
Upgrade
Buildings
1,6241,6241,6241,6241,624
Upgrade
Machinery
3,6423,3203,0592,9522,433
Upgrade
Construction In Progress
----278.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.